ACTRN12618000691246已完成不适用
HIV Disease and Impairment of High Density Lipoprotein Metabolism
Baker Heart and Diabetes Instutite0 个研究点目标入组 70 人开始时间: 2018年4月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
4 期
A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop LipodystrophyLipodystrophyHIV InfectionsNCT00006190National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
已完成
不适用
Understanding the Increased Risk of Cardiovascular Disease in People With HIVHIV InfectionsNCT00577681University of Minnesota5,472
招募中
4 期
HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA 001)HIVMetabolic abnormalityLipodystrophyInfection - Acquired immune deficiency syndrome (AIDS / HIV)Cardiovascular - Other cardiovascular diseasesCardiovascular diseaseACTRN12605000662662The University of New South Wales80
已完成
不适用
Changes in lipid profile in people living with HIV on stable protease inhibitors (PIs)-based regimens as second-line ART regimens switch to dolutegravir (DTG)-based regimenspeople living with HIVlipid profile, protease inhibitors, second-line ART regimens, switching, dolutegravirTCTR20240717004Faculty of Medicine, Chulalongkorn University144
已完成
4 期
Mechanisms of Lipodystrophy in HIV-Infected PateintsHIV InfectionsNCT00457665University of Texas Southwestern Medical Center56